Eli Lilly and Company

Patent Owner

Follow Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology MATTERS Rank in Class
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 503 24
 
 
C07D HETEROCYCLIC COMPOUNDS 318 17
 
 
C07K PEPTIDES 111 38
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 60 38
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 60 82
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 45 116
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 39 93
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 37 64
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 33 23
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 29 71
  • No Technologies to Display

Top Patents (by citation)

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0368,922 2-OXO-1,3,8-TRIAZASPIRO[4.5]DECAN-3-YL] CARBOXYLIC ACID DERIVATIVES Jun 08, 16 Dec 22, 16 [C07D]
2016/0368,960 GLUCAGON AND GLP-1 CO-AGONIST COMPOUNDS Jun 16, 16 Dec 22, 16 [C07K]
2016/0369,004 ANTI-MET IN COMBINATION WITH ANTI-VEGFR2 ANTIBODIES THERAPY FOR CANCER Feb 25, 15 Dec 22, 16 [A61K, C07K]
2016/0361,390 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA Aug 26, 16 Dec 15, 16 [A61K]
2016/0346,483 INJECTION NEEDLE COVERING SYSTEM Feb 06, 15 Dec 01, 16 [A61M]
2016/0333,005 ISOPROPYL TRIAZOLO PYRIDINE COMPOUNDS Jan 06, 15 Nov 17, 16 [C07D]
2016/0326,208 5'-SUBSTITUTED NUCLEOSIDE COMPOUNDS Apr 27, 16 Nov 10, 16 [C07H]
2016/0318,953 Selective BACE1 Inhibitors Apr 22, 16 Nov 03, 16 [C07D, C07C]
2016/0272,585 Phenoxyethyl Cyclic Amine Derivatives and Their Activity as EP4 Receptor Modulators Dec 11, 14 Sep 22, 16 [C07D]
2016/0251,306 DIMETHYLBENZOIC ACID COMPOUNDS Dec 11, 14 Sep 01, 16 [C07C]

View all publication…

  • No Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,526,733 ERK inhibitors Sep 08, 16 Dec 27, 16 [C07D, A61K, C07K]
9,527,837 Inhibitors of EZH2 Dec 01, 15 Dec 27, 16 [C07D, A61K]
9,527,909 Antibodies to tau and uses thereof Feb 18, 16 Dec 27, 16 [C12P, A61K, C07K]
9,522,923 Selective BACE1 inhibitors Feb 17, 16 Dec 20, 16 [C07D, C07C, A61K]
9,512,140 antagonists Aug 22, 12 Dec 06, 16 [C07D, A61K]
D773650 Automatic injection device Jun 19, 15 Dec 06, 16 [2402]
9,505,838 Method to treat migraines using CGRP antibodies Jun 04, 15 Nov 29, 16 [A61K, G01N, C07K]
9,499,490 Fluorophenyl pyrazol compounds Dec 11, 14 Nov 22, 16 [C07D, A61K]
9,481,688 antagonists Jul 02, 12 Nov 01, 16 [C07D, A61K]
9,474,780 GIP and GLP-1 co-agonist compounds Jan 05, 16 Oct 25, 16 [A61K, C07K]

View all Patent…

  • No Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0376,178 Pyridinoylpiperidines As 5-HT1F Agonists ABAN Jun 05, 14 Dec 31, 15 [C07D]
2015/0322,083 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS SELECTIVE 5-HT2A INVERSE AGONISTS ABAN Apr 22, 15 Nov 12, 15 [C07D]
2015/0258,177 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA ABAN Jun 02, 15 Sep 17, 15 [A61K]
2015/0203,471 METHODS FOR IMPROVING CHICKEN PRODUCTION ABAN Sep 24, 13 Jul 23, 15 [C07D, C07C, A23K]
2015/0152,158 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Feb 10, 15 Jun 04, 15 [C07K]
2015/0141,335 THERAPEUTIC USES OF FIBROBLAST GROWTH FACTOR 21 PROTEINS ABAN May 09, 13 May 21, 15 [A61K]
2015/0045,313 Ectoparasiticidal Methods and Formulations ABAN Oct 28, 14 Feb 12, 15 [A01N]
2014/0271,671 RANDOM HOMOZYGOUS GENE PERTURBATION (RHGP) WITH THERMAL ASSYMETRIC INTERLACED (TAIL)-PCR ABAN Mar 14, 13 Sep 18, 14 [C12Q]
2014/0275,049 SUBSTITUTED PYRAZOLE ANALOGS As RAR ANTAGONISTS ABAN Oct 19, 12 Sep 18, 14 [C07D, A61K]
2014/0206,613 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Mar 31, 14 Jul 24, 14 [C07K]
2014/0206,877 NOVEL INTERMEDIATE AND PROCESS USEFUL IN THE PREPARATION OF -(2-CHLOROPHENYL)-METHANONE ABAN Mar 27, 14 Jul 24, 14 [C07D]
2014/0171,497 ANIMAL SUPPLEMENTS AND COMPOSITIONS CONTAINING SOLUABLE MONENSIN AND METHODS THEREFOR ABAN Jul 26, 12 Jun 19, 14 [A23K, A61K]
2014/0163,097 ANIMAL SUPPLEMENTS AND FOOD COMPOSITIONS CONTAINING SOLUBLE MONENSIN COMPOSITION, AND METHODS AND PROCESSES THEREFOR ABAN Jul 26, 12 Jun 12, 14 [A23K, A61K]
2014/0056,893 Homodimeric Proteins ABAN Aug 15, 13 Feb 27, 14 [C07K]
2014/0050,763 MODIFIED VIRAL PARTICLES WITH IMMUNOGENIC PROPERTIES AND REDUCED LIPID CONTENT USEFUL FOR TREATING AND PREVENTING INFECTIOUS DISEASES ABAN Oct 30, 13 Feb 20, 14 [A61K]
2014/0024,586 USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY ABAN Oct 03, 13 Jan 23, 14 [A61K]
2013/0228,136 LIQUID DISPENSER ABAN Apr 17, 13 Sep 05, 13 [A01K]
2013/0023,471 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Sep 14, 12 Jan 24, 13 [A61P, A61K]
2012/0323,001 BACE INHIBITORS ABAN Aug 16, 12 Dec 20, 12 [C07D]
2012/0302,547 NOVEL MCH RECEPTOR ANTAGONISTS ABAN Aug 08, 12 Nov 29, 12 [C07D, A61P, A61K]

View all Patent…

  • No Patents to Display

Top Inventors for This Owner

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

Owner Follow
Eli Lilly and Company
CANCEL
UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to comparisons!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of portfolios () for this membership level. Upgrade to our Level for up to portfolios!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of patents allowed in portfolios () for this membership level. Upgrade to our Level for up to patents!

UPGRADE MEMBERSHIP CANCEL